Delivery Order SPE2DB22D3016-SPE2DB23FBCX4
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,563,324,180 units of Naloxone HCL 4 mg Nasal Spray, an opioid overdose reversal medication. The contract has a ceiling value of $8,728.30 and a period of performance through January 16, 2024. The contract was awarded on a firm fixed-price basis and was not subject to any set-aside requirements. Amerisourcebergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,568,008,836 units of Naloxone HCl 4 mg Nasal Spray, a medication used to treat opioid overdose. The contract has a ceiling value of $1,171.34 and a period of performance through April 24, 2025. This award is not set aside for any specific business category. AmerisourceBergen Drug...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,559,464,440 units of 4 mg Naloxone HCl nasal spray, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $2,737.24 and an ultimate completion date of December 29, 2022. This award is part of a larger Indefinite Delivery Contract (IDC)...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,567,908,804 units of Naloxone HCL 4 mg Nasal Spray 2s, a critical medication used to treat opioid overdoses. The contract has a ceiling value of $1,437.31 and a completion date of April 15, 2025. It is a firm fixed-price contract with no set-aside designation,...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of 4,562,139,657 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the treatment of opioid overdose. The contract has a ceiling value of $1,199.86 and a completion date of September 13, 2023. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of 4,567,598,248 units of Naloxone HCL 4 mg Nasal Spray, a critical medication used to treat opioid overdose. The contract has a ceiling value of $22,819.19 and runs through March 18, 2025. This delivery order is part of a larger Indefinite Delivery Contract...
- This federal contract award, valued at $1,199.86, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,562,071,512 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used for the treatment of opioid overdose. The contract has a completion date of September 7, 2023 and is a firm fixed-price delivery order. There was no set-aside designation for this award, indicating full and open...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,562,549,272 units of Naloxone HCl 4 mg Nasal Spray, a critical medication used to treat opioid overdoses. The contract has a total ceiling value of $3,275.59 and a completion date of October 23, 2023. This award is part of a larger Indefinite Delivery Contract (IDC) that...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,767,954 units of Naloxone HCL 4 mg Nasal Spray 2S, a critical medication used to reverse opioid overdoses. The contract has a ceiling value of $1,626.00 and a completion date of July 14, 2025. The contract is not set-aside and was awarded on July 11, 2025....
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Naloxone HCl 4 mg nasal spray, a critical medication used to reverse opioid overdose. The contract has a ceiling value of $3,313.76 and will run through January 29, 2025. It is a firm fixed-price contract, with no set-aside designation. Amerisourcebergen holds a significant...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB23FBCX4Delivery Order
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4,560,986,360 units of Naloxone HCl 4 mg Nasal Spray 2S, a medication used to treat opioid overdose. The contract has a ceiling value of $7,085.57 and an ultimate completion date of May 19, 2023. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that plays a critical role in supplying medical products to federal government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. The company holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for delivering a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.1k | 5/18/23 |